Navigation Links
Helping Young Women Succeed in Today's Unpredictable World
Date:2/17/2009

are seeking a new position."

An Ally for Women

"The post-college decade has always been a challenging time, but today's young women face obstacles unlike any generation before them," explains Andrea Porzio, Group Product Manager of Consumer Marketing at Duramed. "When the unexpected happens -- such as birth control failure or unprotected sex -- Plan B(R) emergency contraception provides women with a back-up plan. This new website extends that support to other areas of a young woman's life, providing a real ally that's easily accessible anytime, anywhere when she needs it the most."

Plan B(R) should be taken as soon as possible within 72 hours (3 days) of unprotected sex or contraceptive failure. Take the first pill as soon as possible, and the second pill 12 hours later. Plan B(R) is not a substitute for primary birth control methods and should not be used that way because it is not as effective. Plan B(R) isn't effective if you're already pregnant, and it won't terminate an existing pregnancy. Plan B(R) does not protect against HIV and other sexually transmitted diseases (STDs). Side effects may include nausea, abdominal pain, fatigue, headache, changes in your period, dizziness, and breast tenderness. If your period is more than a week late, you may be pregnant. If you have severe abdominal pain, you may have an ectopic pregnancy and should get immediate medical help. You are encouraged to report negative side effects of prescription drugs to the FDA at fda.gov/medwatch or call 1-800-FDA-1088.

Additional Information

For more information, please see full prescribing information on www.go2planb.com, call 1-800-330-1271, or speak to your pharmacist.

References:

  1. Preparing for Their Future: A Look at t
    '/>"/>

SOURCE Duramed Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
2. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
3. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
4. Global Vision Recognized for Helping Pharmaceutical Companies Achieve Complete Artwork and Copy Accuracy in their Packaging Process
5. Bioamber announces worlds first bio-based succinic acid plant: helping to reduce dependence on fossil fuels
6. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
7. Youngs experiment in a hydrogen molecule
8. Young Physicians Demanding Advanced Laparoscopic Energy Instruments
9. Genome Technology Magazine Names Top Young Investigators of 2007
10. The neural basis of number sense in young infants
11. Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 LayerBio is an MIT ... wound care. The National Eye Institute (NEI) at the ... Phase I SBIR grant to develop a drug-eluting intraocular ... most common cause of vision loss in people over ... According to Dr. Ken Mandell, LayerBio’s Founder and CEO, ...
(Date:12/19/2014)... The empty capsules market is experiencing ... and technological innovations in the empty capsules market. ... the growth of the empty capsules market. , ... Scope of Report , The report will enrich ... firms to gauge the pulse of the market ...
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... Technology Inc. , the company whose automated computer system ... extending its market reach with a new acquisition. , ... based here, acquired Equipsoft Corp. , a Knoxville, ... ,"Equipsoft offers a complementary product line. The combined enterprises ...
... - Speaking at last week's state biotechnology conference, former governor ... a man with higher office on his mind. Make that ... of Wisconsin in 1998 and who resigned as U.S. ... disgruntled with the Bush White House , would ordinarily ...
... Department of Commerce has qualified seven small ... Investor and Venture Fund Tax Credit programs. , ... technology and biotechnology companies, offer Wisconsin income tax credits ... funds. People that invest in qualified businesses can claim ...
Cached Biology Technology:Eagle Technology acquires some synergy 2Tommy Thompson's Iowa strategy isn't far-fetched 2Tommy Thompson's Iowa strategy isn't far-fetched 3Tommy Thompson's Iowa strategy isn't far-fetched 4Commerce qualifies seven for investor tax credits 2
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems ... http://photos.prnewswire.com/prnh/20130307/600769 The North American ... CAGR of 3.6% from 2014 to 2019. Although the ... Canada is expected to grow ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... addition of the "Samsung Galaxy S5 - ... report to their offering. ... totally different sensing technology than the iPhone 5S, ... sensor in its product. The Galaxy ...
(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... 2012; Wiley-Blackwell, the scientific, technical, medical and scholarly publishing ... two new interdisciplinary review publications: WIREs Developmental Biology ... WIREs Developmental Biology will focus on ... fully patterned adult organism. Edited by John C. Gerhart ...
... for Molecular Medicine (MDC) Berlin-Buch and of the Excellence Cluster ... the Helmholtz Association over the next two years. The grant ... to treat diseases that are caused by protein misfolding. These ... by the MDC, a member institution of the Helmholtz Association, ...
... BOSTON (February 23, 2012, 5:00 pm ET) Researchers ... in vitro and in vivo study, published today in ... stimulates the growth of blood vessels and promotes re-growth of ... new treatment for chronic and acute wounds. The ...
Cached Biology News:Wiley-Blackwell launches 2 interdisciplinary review titles in developmental and membrane biology 2Accelerated search for active agents to treat Alzheimer's and Parkinson's 2Novel bioactive peptides promote wound healing in vivo 2Novel bioactive peptides promote wound healing in vivo 3
...
...
... cytostatic and anti-viral agent. Inhibits several important steps ... formation of HUVEC cells. Also reduces intracellular reactive ... IL-8 release of endothelial cells. ... 16 O 8 MolWeight: ...
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
Biology Products: